Avoid subjective, empirically and time consuming KT/v calculations / assessments & dry weight assessments

BioScan touch i8 can provide qualitative information for assessing volume status.

Over estimation of Dry Weight with subsequent poor blood pressure control impairs the survival and quality of life of HD patients. Expansion of extracellular volume has been associated with hypertension, left ventricular hypertrophy and a higher mortality rate. Likewise, underestimation of Dry Weight results in episodes of hypotension, cramps and faintness effecting dialysis adequacy and contributing to the development of angina and ischemic cerebrovascular disease.

Dry Weight/Volume Status

Optimal Dry Weight is important but difficult to establish with only clinical criteria, especially for complicated patients. The effects of malnutrition could also have an adverse effect. Assessment of Total Body Water (TBW), Extracellular (ECW) and Intracellular Water (ICW) volume should be performed especially after removal or aggressive intervention of fluid therapy in dialysis, Sepsis, Trauma and Malnutrition patients.

Take Control, Make a Difference & Be Proactive

BioScan touch i8 fast, easy and accurate early assessment can help prevent cardiovascular morbidity in dialysis patients. Prevent cardiovascular events, monitor euvolemia status in order to normalise blood pressure. Detect and understand changes in body composition, particularly malnutrition which is common in patients receiving long-term hemodialysis.

Key Features

  • Pre Mid & Post Assessment
  • Intravascular  (IVF verison only)
  • Extravascular  (IVF verison only)
  • Total Body Balance
  • Interstitial Fluid  (IVF verison only)
  • EVF / IVF  (IVF verison only)
  • Plasma  (IVF verison only)
  • Red Cells (IVF verison only)
  • Hematocrit (IVF verison only)
  • Over Hydration (OH) Excess Fluid
  • Dehydration
  • Historical Tracking
  • Dry Weight
  • Over Hydration (OH) (Excess Fluid)
  • Pre, Mid, Post Assessment
  • Dehydration (DH) Status
  • Extracellular Water
  • Intracellular Water
  • Total Body Water
  • Ultrafiltration Rate (UFR)
  • Kt/v
  • Fat Free Mass Hydration
  • Malnutrition Index
  • Body Cell Mass
  • Cellular Biomarker

Early Screening & Identify Patients at Risk

Early diagnosis plays an important role in patient care and research. BioScan touch i8 provides advance, accurate diagnosis which can lead to decision making tailored to correct understanding of patient’s health problems before clinically apparent.

Establish the base line and track the changes. Improve patient outcome, discharge timing and decrease long term complications. Early detection before clinically apparent and better life choices.

  • Advance detection of onslaught of Extracellular Fluid (ECW) excess fluid
  • Monitor Overhydration and Underhydration
  • Pre, Mid, Post Assessment
  • Ultrafiltration Rate (UFR) and Kt/v assessment

 

Guide Medical Therapy to Achieve Optimal Hydration Status

A Positive Health Outcome for Better Life Choices

BioScan touch i8 assessment provide healthcare professionals with an objective measure of a patient, providing targets for interventions which could improve patient experience and outcomes.

BioScan touch i8 provides clinicians with graphic experience and visuals of patient data along with targets and goals achieved. The tracking allows the historical patient data to be analysed and compared. Important estimation of UFR and KTV are automatically provided by BioScan touch i8 in order to optimise dialysis doses. Tests can be assigned as Pre, Mid or Post and fluid changes calculated automatically.

Working in partnership with NHS Supply Chains:

NHS Supply Chain: Diagnostic, Pathology & Therapy Technologies and Services for the provision of Renal Replacement Therapies Services, Technologies and Consumables email: renal@supplychain.nhs.uk

Request a copy of our Brochure

Get in touch

Maltron International Ltd
20 Sirdar Road, Rayleigh,
Essex, SS6 7XF

Tel: +44 (0)1268 778251
Fax: +44 (0)1268 745176

Email: info@maltronint.com

The new BioScan touch i8

Smart technology that understands your
language, learns from your experience and helps provide better patient outcome.

The Body Composition Monitor of tomorrow defining new standards.

View the New BioScan touch i8

Copyright © Maltron International Ltd